Product Program year 2023 Source: CMS Open Payments

Zyclara

Drug Dermatology

NDC 99207-270-28

Open in the dashboard

General payments

$943

19 payments

Research payments

$0

0 payments

Through program year 2023, $943 in general payments and $0 in research payments were reported against Zyclara (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $674 5
2022 General $79 4
2021 General $106 5
2020 General $83 5

Breakdown

Who paid General payments · program years 2020–2023
  1. Ortho Dermatologics, a division of Bausch Health US, LLC $674 5 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $190 10 payments
  3. Bausch & Lomb Americas Inc. $79 4 payments
Top recipients General payments · program year 2023
  1. Clay Cockerell Dermatopathology · Dallas, TX $135 20% · 1 payment
  2. David Glaser Retina Specialist · Florissant, MO $135 20% · 1 payment
  3. Dee Glaser Dermatology · Saint Louis, MO $135 20% · 1 payment
  4. Aaron Farberg MOHS-Micrographic Surgery · Rockwall, TX $135 20% · 1 payment
  5. Ella Glaser Dermatology · New York, NY $135 20% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Dermatology $270 40% · 2 practitioners
  2. MOHS-Micrographic Surgery Dermatology $135 20% · 1 practitioner
  3. Retina Specialist Ophthalmology $135 20% · 1 practitioner
  4. Dermatopathology Dermatology $135 20% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Missouri $405 60% · 3 recipients
  2. Arkansas $135 20% · 1 recipient
  3. Texas $135 20% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

19 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record